Medicare Enrolled

Dr. Murali Veeramachaneni, M.D.,P.A.

Psychiatry · Amarillo, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
22 CARE CIR, Amarillo, TX 79124
8063548300
In practice since 2005 (20 years)
NPI: 1851374367 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Veeramachaneni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Veeramachaneni? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Veeramachaneni

Dr. Murali Veeramachaneni is a psychiatry in Amarillo, TX, with 20 years in practice. Based on federal Medicare data, Dr. Veeramachaneni performed 906 Medicare services across 262 unique beneficiaries.

Between the years covered by Open Payments, Dr. Veeramachaneni received a total of $5,904 from 25 pharmaceutical and/or device companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Veeramachaneni is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 11% volume in TX$ $5,904 industry payments

Medicare Practice Summary

Medicare Utilization ↗
906
Medicare services
Top 11% in TX for psychiatry
262
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~45 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)709$55$94
Hospital follow-up visit, moderate complexity144$59$81
Initial hospital admission, high complexity30$114$223
Hospital discharge day management, 30 minutes or less23$61$83
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,904
Total received (2018-2024)
Avg $843/year across 7 years
Top 11% in TX for psychiatry
25
Companies
438
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,904 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$865
2023
$895
2022
$911
2021
$1,085
2020
$536
2019
$901
2018
$711

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$1,081
Otsuka America Pharmaceutical, Inc.
$936
AbbVie Inc.
$507
Sunovion Pharmaceuticals Inc.
$448
Takeda Pharmaceuticals U.S.A., Inc.
$443
Supernus Pharmaceuticals, Inc.
$315
Lundbeck LLC
$283
Corium, LLC
$254
Teva Pharmaceuticals USA, Inc.
$238
ITI, Inc.
$224
Alkermes, Inc.
$215
ABBVIE INC.
$141
Tris Pharma Inc
$133
Allergan, Inc.
$118
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$111
Merck Sharp & Dohme Corporation
$107
Axsome Therapeutics, Inc.
$77
Janssen Pharmaceuticals, Inc
$62
Allergan Inc.
$57
Ironshore Pharmaceuticals Inc.
$41
IDORSIA PHARMACEUTICALS US INC
$34
Shire North American Group Inc
$24
Otsuka Pharmaceutical Development & Commercialization, Inc.
$22
IRONSHORE PHARMACEUTICALS INC.
$18
E.R. Squibb & Sons, L.L.C.
$16
Top 3 companies account for 42.7% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ARISTADA · AUSTEDO · AZSTARYS · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · Dyanavel XR · Entyvio · INGREZZA · INVEGA SUSTENNA · JORNAY PM · LATUDA · LYBALVI · ONGENTYS · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · Quillivant XR · REXULTI · SPRAVATO · TRINTELLIX · Trintellix · VRAYLAR · VYVANSE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $652 per 100 Medicare services performed
Looking for a psychiatry in Amarillo?
Compare psychiatrys in the Amarillo area by procedure volume, costs, and industry payment transparency.
Browse psychiatrys nearby

Geographic Context

Psychiatrys within 10 mi
21
Per 100K population
18.0
County median income
$50,448
Nearest hospital
QUAIL CREEK SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Veeramachaneni is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), and high industry engagement (low-engagement, top 11%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Veeramachaneni experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Veeramachaneni performed 709 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Veeramachaneni receive payments from pharmaceutical companies?
Yes. Dr. Veeramachaneni received a total of $5,904 from 25 companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Veeramachaneni's costs compare to other psychiatrys in Amarillo?
Dr. Veeramachaneni's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Veeramachaneni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →